111 related articles for article (PubMed ID: 11713378)
1. Leukaemic transformation in a case of thrombocythaemia. Case report and review of the literature.
Quaglino D; Di Leonardo G; Stati M
Acta Haematol; 2001; 106(3):122-5. PubMed ID: 11713378
[TBL] [Abstract][Full Text] [Related]
2. The histopathology of chronic myeloproliferative diseases.
Georgii A; Buesche G; Kreft A
Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
[TBL] [Abstract][Full Text] [Related]
3. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
[TBL] [Abstract][Full Text] [Related]
4. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.
Emilia G; Sacchi S; Temperani P; Longo R; Vecchi A
Leuk Lymphoma; 1993 Mar; 9(4-5):423-6. PubMed ID: 8348078
[TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic transformation of a myeloproliferative disorder.
Prematilleke MN; Cheng PN; Feng CS
Ceylon Med J; 1989 Dec; 34(4):179-84. PubMed ID: 2627727
[TBL] [Abstract][Full Text] [Related]
6. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; Kutti J; Swolin B; Ridell B; Fernando P; Zanetto U
Ann Hematol; 2004 Aug; 83(8):504-12. PubMed ID: 15164229
[TBL] [Abstract][Full Text] [Related]
7. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid, and megakaryocytic lineages.
Kimura A; Fujimoto T; Inada T; Imamura N; Oguma N; Kajihara H; Mtasiwa DM; Katoh O; Fujimura K; Kuramoto A
Cancer; 1990 Apr; 65(7):1538-44. PubMed ID: 2311065
[TBL] [Abstract][Full Text] [Related]
8. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
10. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
11. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
12. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
13. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
14. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
15. Essential thrombocythaemia and the Philadelphia chromosome.
Morris CM; Fitzgerald PH; Hollings PE; Archer SA; Rosman I; Beard ME; Heaton DC; Newhook CJ
Br J Haematol; 1988 Sep; 70(1):13-9. PubMed ID: 3179224
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.
Thiele J; Kvasnicka HM
Histol Histopathol; 2003 Jan; 18(1):93-102. PubMed ID: 12507288
[TBL] [Abstract][Full Text] [Related]
17. [Thrombocythaemia - is there a primary form? ((author's transl)].
Hartwich G; Schirmbeck H; Mörl M
Med Klin; 1975 Dec; 70(49):2005-8. PubMed ID: 1060913
[TBL] [Abstract][Full Text] [Related]
18. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Passamonti F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
Hernández JM; San Miguel JF; González M; Moraleda JM; Moro MJ; Hernández J; Cuesta B; López Borrasca A
Med Clin (Barc); 1991 Sep; 97(10):369-72. PubMed ID: 1745085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
